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Abstract. 
 
During tissue-invasive events, migrating cells 
penetrate type I collagen-rich interstitial tissues by mo-
bilizing undeﬁned proteolytic enzymes. To screen for 
members of the matrix metalloproteinase (MMP) fam-
ily that mediate collagen-invasive activity, an in vitro 
model system was developed wherein MDCK cells 
were stably transfected to overexpress each of ten dif-
ferent MMPs that have been linked to matrix remodel-
ing states. MDCK cells were then stimulated with scat-
ter factor/hepatocyte growth factor (SF/HGF) to 
initiate invasion and tubulogenesis atop either type I 
collagen or interstitial stroma to determine the ability 
of MMPs to accelerate, modify, or disrupt morphogenic 
responses. Neither secreted collagenases (MMP-1 and 
MMP-13), gelatinases (gelatinase A or B), stromelysins 
(MMP-3 and MMP-11), or matrilysin (MMP-7) af-
fected SF/HGF-induced responses. By contrast, the 
membrane-anchored metalloproteinases, membrane-
type 1 MMP, membrane-type 2 MMP, and membrane-
type 3 MMP (MT1-, MT2-, and MT3-MMP) each
modiﬁed the morphogenic program. Of the three
MT-MMPs tested, only MT1-MMP and MT2-MMP 
were able to directly confer invasion-incompetent cells 
with the ability to penetrate type I collagen matrices. 
MT-MMP–dependent invasion proceeded indepen-
dently of proMMP-2 activation, but required the en-
zymes to be membrane-anchored to the cell surface. 
These ﬁndings demonstrate that MT-MMP–expressing 
cells can penetrate and remodel type I collagen-rich tis-
sues by using membrane-anchored metalloproteinases 
as pericellular collagenases.
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Introduction
 
During (patho)physiologic events ranging from growth
and development to tumor invasion and metastasis, nor-
mal or neoplastic cells traverse tissue barriers comprised
largely of type I collagen, the major structural component
of the extracellular matrix (Liu et al., 1995; Pulcher et al.,
1997; Benbow et al., 1999; Murphy and Gavrilovic, 1999).
Whereas the collagen matrix is presumably remodeled
during cell ingress, the triple-helical structure of type I col-
lagen renders the molecule resistant to almost all forms of
proteolytic attack save, in large part, to members of the
matrix metalloproteinase (MMP)
 
1
 
 gene family (Birkedal-
Hansen, 1987; Nagase and Woessner, 1999). Interestingly,
though several MMPs have been linked to the degradation
of type I collagen during tissue-resorptive events, the iden-
tity of those proteinases that allow migrating cells to in-
vade or remodel type I collagen barriers remains unde-
fined (Benbow et al., 1999).
Beyond the identification of the specific MMPs that pro-
mote collagen degradation, additional constraints compli-
cate our ability to understand the manner in which these
systems are mobilized during invasive processes. First,
MMPs are uniformly synthesized as inactive zymogens
with latency maintained by the enzymes’ prodomains.
Hence, the expression of degradative activity usually re-
quires a bimolecular proteolytic processing event wherein
the MMP prodomain is removed (Nagase and Woessner,
1999). Secondly, the invading cell must either position the
type I collagenase activity on its surface in a manner that
allows tissue-invasive signals to be interpreted accurately
or induce collagenolytic activity in surrounding cell popu-
lations in a spatially regulated manner (Werb, 1997; Mur-
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phy and Gavrilovic, 1999). Thirdly, both the processing of
the MMP zymogen to its mature form and the retention of
the enzyme’s collagenolytic activity must take place in tis-
sues that are normally bathed in high concentrations of
circulating antiproteinases (Weiss, 1989).
Whereas solitary cells can display invasive phenotypes,
branching morphogenesis requires cells to invade and re-
model the surrounding collagen matrix in a coordinated
fashion to ultimately establish a defined structure (Gum-
biner, 1992; Birchmeier and Birchmeier, 1993). As collagen-
degrading MMPs would be predicted to either enhance or
modify such tubulogenic programs, we reasoned that an in
vitro model that recapitulates a morphogenic process
would provide a sensitive platform for identifying the sub-
set of proteinases that participate in the remodeling of the
type I collagen matrix. MDCK cells are highly differen-
tiated epithelial cells that can be induced to undergo
branching morphogenesis in type I collagen matrices in
response to the morphogen, scatter factor/hepatocyte
growth factor (SF/HGF; Montesano et al., 1991a,b, 1999).
As such, we stably transfected MDCK cells to overexpress
each of ten different MMPs that previously have been
linked to invasive/morphogenic states (Nagase and Woess-
ner, 1999), and examined the ability of these cells to inter-
pret proinvasive, as well as tubulogenic signals. Surpris-
ingly, seven of the ten secreted MMPs tested, which
included the type I collagenases: MMP-1 (collagenase 1),
MMP-13 (collagenase 3), and MMP-2 (gelatinase A), failed
to modulate invasion or morphogenic responses. How-
ever, three MMPs were identified that either accelerated,
disrupted, or modified branching tubulogenesis. Interest-
ingly, this subset of proteinases all belong to the mem-
brane-anchored family of MMPs (i.e., the membrane-type
MMPs [MT-MMPs]; Murphy and Gavrilovic, 1999; Na-
gase and Woessner, 1999). The ability of membrane-
anchored, rather than secreted, MMPs to regulate the SF/
HGF-dependent tubulogenic program suggests that this
class of enzymes has been specifically engineered to medi-
ate pericellular proteolytic processes associated with cell
invasion and morphogenesis through type I collagen-rich
barriers.
 
Materials and Methods
 
Cell Culture
 
All cell lines were obtained from ATCC. MDCK and COS-1 cell lines
were routinely maintained in complete medium: DME supplemented with
10% FCS (Atlanta Biologicals), 2 mM 
 
L
 
-glutamine, penicillin (100 U/ml),
and streptomycin (100 
 
m
 
g/ml), all from Life Technologies. Stably trans-
fected MDCK cell lines were maintained in normal medium containing
700 
 
m
 
g/ml geneticin (G418; Life Technologies). All cells were cultured at
37
 
8
 
C in a 5% CO
 
2
 
/95% air atmosphere.
 
Expression Vector Construction and Transfection
 
Full-length cDNAs were generated using the following primer sets: MT1-
MMP, forward TCT CGG ACC ATG TCT CCC GCC CCA, reverse
CTA TCA GAC CTT GTC CAG CAG GGA; MT2-MMP, forward
GGG CGC CGA GAG CAT GGG CAG; reverse CTA TCA GAC CCA
CTC CTG CAG CGA; MT3-MMP, forward GCA CAG TTC ACT ATG
ATC TTA CTC, reverse CTA CTA CAC CCA CTC TTG CAT AGA;
MMP-9 (gelatinase B), forward CTC ACC ATG AGC CTC TGG CAG
CCC, reverse TAG TCC TCA GGG CAC TGC AGG ATG; MMP-2 (ge-
latinase A), forward GGG AGC GCT ACG ATG GAG GCG CTA, re-
 
verse CCA GGG CCA GCT CAG CAG CCT AGC; MMP-3 (strome-
lysin-1), forward GTA AAG CCA GTG GAA ATG AAG AGT, reverse
CTA TCA ACA ATT AAG CCA GCT GTT. The resulting full-length
PCR products were cloned into pCR3.1 Uni vector (Invitrogen) according
to the manufacturer’s instructions. Full-length MMP-1 (collagenase-1)
cDNA was obtained by assembling a 5
 
9
 
 PCR fragment (using a primer set
consisting of: forward, GGA AGC TTA CCT TGC ACT GAG AAA G,
reverse TCC AAT ACC TGG GCC TGG T) and an XbaI fragment con-
taining the 3
 
9
 
 end of human MMP-1 isolated from p35-1 (ATCC). Full-
length human MMP-13 (collagenase-3; provided by Peter Mitchell, Pfizer,
Groton, CT) was subcloned as a HindIII fragment in pCR3.1 Uni. Full-
length human MMP-7 (matrilysin) cDNA was provided by Lynn Matri-
sian (Vanderbilt University, Nashville, TN) and subcloned in pCR3.1 Uni
as an EcoRI fragment. Full-length MMP-11 cDNA (Pei et al., 1994) was
subcloned into the HindIII/XbaI sites of pCR 3.1 Uni from pREP9. Solu-
ble MT1-MMP (
 
D
 
MT1-MMP; Met
 
1
 
-Gly
 
535
 
), which lacks the COOH-ter-
minal transmembrane and cytosolic domains of the wild-type proteinase,
and a cytosolic tail-truncated mutant MT1-MMP (MT1-MMP
 
ct; 
 
Met
 
1
 
 
to
Phe
 
563
 
) were generated as described (Ohuchi et al., 1997; Hiraoka et al.,
1998). To generate soluble MT2-MMP (
 
D
 
MT2-MMP; Met
 
1
 
-Asn
 
625
 
), a
BstEII–XhoI fragment was excised from a full-length MT2-MMP expres-
sion plasmid and replaced with a PCR fragment synthesized using a
primer set consisting of: forward, TGT CTT TTT CAA AGG TGA CCG
CTA CTG GCT CT, reverse, AGA CTC GAG CGG CCA ATT TCA
GTT CAC CGT CCG TGC CAC CTC CTC CA. Epitope-tagged MT1-,
MT2-, and MT3-MMP constructs were generated by inserting primers en-
coding the FLAG epitope (5
 
9
 
-GAC TAC AAG GAC GAC GAT GAC
AAG-3
 
9
 
) after the COOH-terminal valine of each molecule and cloned
into pCR3.1 Uni.
Stably transfected MDCK cell lines were generated using lipofectamine
(Life Technologies) according to the manufacturer’s instructions. After
transfection, single colonies were isolated after 2–3 wk of G418 selection.
For stable transfectants, results shown are representative of three or more
clones tested. COS-1 cells were transiently transfected using lipofectamine
in the same manner, but without G418 selection.
 
Cell Proliferation, Scattering, and Migration Assays
 
To measure cell proliferation rates, 5 
 
3
 
 10
 
4
 
 cells were plated into each
well of a 12-well tissue culture plate (Costar, Corning Inc.) and cultured
for 3, 5, or 7 d in complete medium as described above. At each time
point, the cells were harvested by trypsinization and counted using a he-
macytometer. Cell scattering was assessed by seeding 2 
 
3
 
 10
 
5
 
 cells/well in
6-well tissue culture plates (Costar, Corning Inc.). After 18–24 h, the cul-
ture medium was replaced with fresh culture medium either alone or con-
taining 50 ng/ml SF/HGF (Genentech, Inc.). After an additional 24 h, the
cultures were examined using phase-contrast optics and photographed.
Cell migration rates were assessed by seeding 2–5 
 
3
 
 10
 
5
 
 cells atop collagen
gels with surfaces partially covered by glass coverslips (1 
 
3
 
 2 mm; Corning
Inc.). When the cells reached confluence, the glass fragments were re-
moved, leaving a well-demarcated, cell-free area on the gel. At this time,
SF/HGF (50 ng/ml) was added to all cultures in the absence or presence of
the synthetic MMP inhibitor, BB-94 (5 
 
m
 
M; gift of British Biotechnology)
and the distances migrated across the gels were measured 24 h later using
an ocular micrometer on a Nikon inverted microscope.
 
Invasion and Tubulogenesis Assays
 
Collagen.  
 
Type I collagen was prepared from rat tail tendons as described
(Elsdale and Bard, 1972) and dissolved in 0.2% acetic acid to a final con-
centration of 2.7 mg/ml. To induce gelling, collagen was mixed with 10
 
3
 
DME and 0.34 N NaOH in an 8:1:1 ratio at 4
 
8
 
C, and 1 ml of this mixture
was added to the upper well of a 24-mm Transwell dish (3-
 
m
 
m pore size;
Corning, Inc.). After gelling was complete (45 min at 37
 
8
 
C), 2–5 
 
3 
 
10
 
5
 
cells in complete medium were added to the upper well. After an addi-
tional 24-h incubation period, SF/HGF was added to the lower compart-
ment of the Transwell chambers at a final concentration of 50 ng/ml. In in-
dicated experiments, protease inhibitors were added to both the upper
and lower wells at the following final concentrations: 5 
 
m
 
M BB-94 (0.1%
DMSO; final concentration); 200 ng/ml recombinant tissue inhibitor of
metalloproteinase-1 (TIMP-1; Oncogene Research Products); 200 ng/ml
recombinant TIMP-2 (gift of Amgen, Thousand Oaks, CA); 200 
 
m
 
g/ml
aprotinin; 10 
 
m
 
M bestatin; 100 
 
m
 
g/ml soybean trypsin inhibitor (SBTI);
100 
 
m
 
M E64 (0.1% ethanol; final concentration); and 50 
 
m
 
M pepstatin
(0.1% methanol; final concentration; all from Sigma-Aldrich). None of
the solvents used affected MDCK or COS-1 cell behavior when tested 
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alone. FCS was depleted of plasminogen or gelatinase, respectively, by
lysine-sepharose or gelatin-sepharose (both from Amersham Pharmacia
Biotech) affinity chromatography (Rosenthal et al., 1998). All media, in-
cluding SF/HGF and inhibitors, were replaced every 2 d. MDCK and
COS-1 invasion assays were routinely terminated after 12 and 5 d, respec-
tively. Invasive foci were counted in randomly selected fields at 20
 
3
 
 on a
phase-contrast microscope. Invasion depths were measured from digitally
captured images of hematoxylin and eosin-stained cross-sections.
 
Matrigel.  
 
Cell invasion into a reconstituted basement membrane ex-
tract was assessed by adding 800 
 
m
 
l of Matrigel (Becton Dickinson) to the
upper well of 24-mm Transwell dishes. After gelling at 37
 
8
 
C for 30 min,
2–5 
 
3
 
 10
 
5
 
 cells were added to the upper compartment. After a 24-h incu-
bation period, the medium was exchanged and SF/HGF (50 ng/ml) was
added to the lower chamber. Media and SF/HGF were replaced every 2 d
in the course of a 12-d incubation period.
 
Peritoneum.  
 
Peritoneum-derived cultures were prepared by gently
stretching fat-free portions of rat gut mesentery (resected from adult male
rats anesthetized and then killed) over the opening of a 12-mm Transwell
from which the polycarbonate membrane had been removed. The mesen-
tery was tied onto the well with surgical silk thread, and the outer edge of
the mesentery below the thread was cut away with a scalpel. Mesothelial
cells were lysed by immersion in 1 N ammonium hydroxide for 1 h at room
temperature. The wells were then rinsed repeatedly in culture medium
and placed inverted in a 15-cm petri dish. A small bolus of type I collagen
(
 
z
 
100 
 
m
 
l) was applied to the bottom of the peritoneum and was gelled for
45 min at 37
 
8
 
C. After gelling, the wells were inverted and placed in clean
12-well dishes and 1–2 
 
3 
 
10
 
5
 
 cells were added to the upper wells onto the
surface of the peritoneum in complete medium. After 24 h, the medium
was exchanged and SF/HGF (50 ng/ml) was added to the lower compart-
ments in the absence or presence of BB-94 as described above.
 
Western Blots and Zymography
 
MMP protein expression by stably transfected clones was assessed by
Western blotting as described (Pei and Weiss, 1995, 1996), with the excep-
tion of MT3-MMP (see below). For secreted MMPs (MMP-1, -2, -3, -7, -9,
-11, and -13), as well as soluble 
 
D
 
MT1-MMP and 
 
D
 
MT2-MMP, MDCK
clones were incubated for 24 h in serum-free medium and supernatants
were collected in the presence of proteinase inhibitor cocktail (Calbio-
chem). MT-MMP proteins were solubilized from Triton X-114–extracted
cells as described by Toth et al. (1997). Supernatants and detergent ex-
tracts were resolved by PAGE under reducing conditions and the proteins
transferred to nitrocellulose membranes. Immunoblot analyses were per-
formed with one of the following antibodies: MMP-1 rabbit polyclonal
(gift of H. Birkedal-Hansen, National Institute of Dental and Craniofacial
Research, Bethesda, MD) at 1:2,000; MMP-2 mouse monoclonal (Molecu-
lar Oncology, Inc.) at 1:2,000; MMP-3 mouse monoclonal (Calbiochem #
IM236L) at 1:200; MMP-7 rabbit polyclonal (gift of H. Welgus, Parke-
Davis, Ann Arbor, MI) at 1:500; MMP-9 rabbit polyclonal (gift of H. Wel-
gus) at 1:5,000; MMP-11 rabbit polyclonal (Pei et al., 1994) at 1:1,000;
MMP-13 rabbit polyclonal (gift of Peter Mitchell, Pfizer, Groton, CT) at
1:2,000; MT1-MMP mouse monoclonal (Calbiochem # IM39L) at 1:500;
MT2-MMP mouse monoclonal (Calbiochem # IM48L) at 1:500; and
mouse monoclonal M2 against a FLAG epitope (Sigma-Aldrich) at 1:1,000.
After incubation with HRP-conjugated anti-mouse or anti-rabbit IgG sec-
ondary antibody, protein bands were visualized using an ECL kit accord-
ing to the manufacturer’s instructions (Pierce Chemical Co.).
The ability of cells to activate MMP-2 was determined by gelatin zy-
mography (Rosenthal et al., 1998). In brief, cells were incubated with se-
rum-free medium containing recombinant proMMP-2. After a 24-h in-
cubation at 37
 
8
 
C, the supernatants were collected and resolved under
nonreducing conditions on 10% polyacrylamide gels impregnated with 2
mg/ml gelatin (Sigma-Aldrich). Gels were rinsed once in 2.5% Triton
X-100 for 30 min at room temperature and then incubated in developing
solution (50 mM Tris-HCl, 5 mM CaCl
 
2
 
, 1 
 
m
 
M ZnCl
 
2
 
, pH 7.6) for 8–16 h.
Gels were stained with Coomassie blue and areas of gelatinolytic activity
were detected as transparent bands.
 
Northern Blot
 
As commercially available MT3-MMP antibodies lacked sensitivity (i.e.,
epitope-tagged MT3-MMP expressed in transiently transfected cells was
detectable with antiepitope, but not anti-MT3-MMP antibodies; see be-
low), stable clones were identified by Northern blot analysis. Total RNA
was isolated from MT3-MMP–transfected and control MDCK cells using
TRIzol reagent (Life Technologies) according to the manufacturer’s in-
structions. RNA (10 
 
m
 
g/lane) was electrophoretically separated in a 1%
agarose-formaldehyde gel, transferred to a nylon filter (Hybond-N; Am-
ersham Pharmacia Biotech) and hybridized with 
 
32
 
P-labeled cDNA
probes for human MT3-MMP and 36B4. Bands were visualized by autora-
diography as described (Rosenthal et al., 1998).
 
Immunofluorescence, Light, and Electron Microscopy
 
E-cadherin immunofluorescence was performed as described (Lochter et
al., 1997a) using a mouse monoclonal E-cadherin antibody (Transduction
Laboratories; # C20820) at 1:100 and Texas red-conjugated anti-mouse
IgG (Vector Laboratories, Inc.). Fluorescent images were captured using
a Spot digital camera (Diagnostic Instruments, Inc.) through a Leica up-
right microscope.
Collagen and Matrigel cultures were prepared for light microscopy af-
ter fixation in 4% paraformaldehyde in PBS. Fixed gels were then re-
moved from the Transwell, dehydrated in a graded ethanol series, and em-
bedded in paraffin. Sections (5–7-
 
m
 
m thick) were cut and stained with
hematoxylin and eosin. For electron microscopy, gels were fixed in 2% glu-
taraldehyde/1.5% paraformaldehyde in 0.1 M sodium cacodylate buffer,
postfixed in 1% osmium tetroxide, and embedded in epoxy resin. Sections
(500-nm thick) were stained with toluidine blue before examining by
transmission electron microscopy (TEM) as described (Hiraoka et al.,
1998). Peritoneum cultures were prepared as for TEM, and bright-field
images of toluidine blue stained sections were captured digitally before
TEM examination.
 
Results
 
Role of Secreted MMPs in Modulating
SF/HGF-induced Invasion/Tubulogenesis
 
When cultured atop type I collagen matrices, MDCK cells
formed confluent monolayers that remained confined to
the surface of the underlying gel for the entire culture pe-
riod (i.e., 12 d; Fig. 1 A). In the presence of SF/HGF, how-
ever, the epithelial cells rapidly invaded the underlying
collagen matrix and assembled into complex branching tu-
bular networks (Fig. 1 B). This SF/HGF-induced invasion/
tubulogenesis program was unaffected either by inhibitors
directed against serine proteinases (SBTI or aprotinin),
cysteine proteinases (E-64), aspartate proteinases (pep-
statin), aminopeptidases (bestatin), or by culturing cells
under plasminogen-depleted conditions (Fig. 1 C). How-
ever, both the synthetic MMP inhibitor, BB-94, and the re-
combinant MMP inhibitor, TIMP-2, completely blocked
the MDCK invasion program (Fig. 1, C and D).
Coincident with invasive programs in vivo, epithelial
cells alone or in collaboration with surrounding stromal
cells express a mix of collagenolytic and gelatinolytic
MMPs that are secreted into the extracellular milieu
(Werb, 1997; Murphy and Gavrilovic, 1999; Nagase and
Woessner, 1999). To determine whether secreted enzymes
that either: directly degrade type I collagen (i.e., MMP-1,
MMP-13, or MMP-2); cooperate in collagenolytic pro-
cesses (i.e., MMP-3, MMP-7, or MMP-9); or display pat-
terns of expression that are tightly associated with inva-
sive/morphogenic processes (i.e., MMP-11), can perturb
invasion and/or branching morphogenesis, stably trans-
fected MDCK clones overexpressing each of the respec-
tive MMPs were cultured atop type I collagen matrices
and stimulated with SF/HGF. Surprisingly, despite the fact
that the synthesis of each of the respective MMPs was in-
creased significantly over wild-type cells (Fig. 2 A), none
of the overexpressed proteinases altered the kinetics of 
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the invasive process or the characteristics of the tubulo-
genic program (Fig. 2, B–I). In data not shown, neither in-
vasion nor tubulogenesis was enhanced when control or
transfected clones were stimulated with SF/HGF under se-
rum-free conditions in the absence or presence of 20 
 
m
 
g/ml
plasminogen.
 
MT1-MMP Accelerates Invasion and Disrupts 
Branching Tubulogenesis
 
Whereas secreted MMPs were unable to modify SF/HGF-
induced type I collagen invasion, membrane-anchored
MMPs could potentially allow cells to more productively
focus collagenolytic activity to the pericellular milieu (Na-
kahara et al., 1997; Hiraoka et al., 1998; Murphy and
Gavrilovic, 1999). After stable transfection with MT1-
MMP cDNA, overexpressing MDCK cells proliferated at
rates comparable to control transfectants (Fig. 3 A) and
displayed normal epithelial morphology, as well as E-cad-
herin staining (Fig. 3 B). Furthermore, MT1-MMP trans-
fectants scattered normally across a plastic 2-dimensional
substratum in response to SF/HGF (Fig. 3 B) and migrated
across the surface of type I collagen gels at rates compara-
ble to control transfectants (i.e., 550 
 
6
 
 23 
 
m
 
m/24 h versus
Figure 1. Invasive and tubulogenic properties
of resting and SF/HGF-stimulated MDCK
cells cultured atop a type I collagen matrix.
A, Unstimulated MDCK cells on a collagen
gel form a monolayer with cells confined to
the gel surface (shown en face) in the top
panel and as an H and E stained cross-section
in the bottom panel. Bar, 100 mm. The dou-
ble-headed arrow in the cross-section marks
the boundaries of the collagen gel. B, After
stimulation for 12 d with SF/HGF (50 ng/ml),
MDCK cells invaded the collagen gel and
formed a complex meshwork of branching tu-
bular structures. C, MDCK invasion by SF/
HGF-stimulated cells was unaffected by in-
hibitors of serine proteinases (200 mg/ml
aprotinin, 100 mg/ml SBTI), cysteine protein-
ases (100 mM E-64), aspartate proteinases (50
mM pepstatin), aminopeptidases (10 mM be-
statin), or serum plasminogen depletion
(2Plg) in the course of a 12-d culture period.
In contrast, BB-94 (5 mM) or recombinant
TIMP-2 (200 ng/ml) completely blocked inva-
sion. Results are shown as the mean number
of invasive foci 6 1 SD in ten randomly se-
lected fields in a single representative experi-
ment of four performed. D, Representative
cross-sections of MDCK cells stimulated with
SF/HGF in the presence of either BB-94 or
TIMP-2 for 12 d. Bar, 100 mm. 
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563 
 
6
 
 40 
 
m
 
m/24 h,
 
 n 
 
5 
 
3, respectively). However, when
MT1-MMP transfectants were cultured atop type I col-
lagen gels and triggered with SF/HGF, invasion was mark-
edly accelerated as early as day three (Fig. 3 C). By day 12,
MT1-MMP transfectants cultured in the absence of SF/
HGF also expressed a degradative activity that resulted in
the formation of well-circumscribed pits. In the presence
of SF/HGF, MDCK cells overexpressing MT1-MMP lost
the ability to form a branching network and instead, com-
pletely degraded the underlying collagen substratum via a
BB-94– or TIMP-2–sensitive process (Fig. 3 D). The addi-
tion of TIMP-1, which, in contrast to TIMP-2 does not ef-
fectively inhibit membrane-anchored metalloproteinases
(Nagase and Woessner, 1999), had no effect on the height-
ened collagenolytic activity of the MT1-MMP transfec-
tants (Fig. 3 D).
To identify structural features of the MT1-MMP mole-
cule critical to the invasive process, stable transfectants
were generated that expressed either a cytosolic tail-
deleted form of the proteinase (MT1-MMP
 
ct
 
) or a soluble,
transmembrane-deleted mutant (
 
D
 
MT1-MMP). Whereas
the enhanced degradative potential of MT1-MMP trans-
fectants was not affected by deleting the cytosolic tail of
the proteinase, membrane anchoring proved essential as
the tubulogenic response of the wild-type phenotype was
recovered when the metalloproteinase was expressed as a
soluble mutant (Fig. 4, A–D). Because the transmem-
brane deletion mutant is secreted as a fully active enzyme
Figure 2. MDCK cells overexpressing se-
creted MMPs display normal invasive and
morphogenic activities. A, Western blots
showing the relative expression levels of the
identified MMPs in control (C) and trans-
fected (T) MDCK cells. Brackets indicate the
positions of the glycosylated and nonglyco-
sylated forms of proMMP-1, proMMP-3, and
proMMP-11, respectively, whereas asterisks
indicate active glycosylated and nonglyco-
sylated forms of MMP-3, or active forms of
MMP-2 and MMP-11. B–I, After stimulation
with SF/HGF for 12 d, the invasion patterns
of control transfectants (B) and the clones
overexpressing each of the indicated MMPs
(C–I) were indistinguishable. Neither control
nor MMP transfectants displayed invasive ac-
tivity in the absence of SF/HGF (data not
shown). Bar, 100 mm. 
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(Pei and Weiss, 1996; Ohuchi et al., 1997), these results in-
dicate that MT1-MMP must be anchored to the cell sur-
face to affect invasion and/or branching morphogenesis.
MT1-MMP not only is able to degrade a range of target
substrates directly, but also indirectly as a function of its
ability to process proMMP-2 or -13 to their active forms
(Knauper et al., 1996; Pei and Weiss, 1996; D’Ortho et al.,
1997; Ohuchi et al., 1997). Thus, we sought to determine
Figure 3. Characterization of MT1-MMP–overexpressing MDCK cells. A, Proliferative response of wild-type (j), vector control-trans-
fected (d), full-length MT1-MMP (h), cytosolic tail-deleted MT1-MMP (MT1-MMPct; n), and soluble MT1-MMP (DMT1-MMP; s)
during a 7-d culture period. Cell number at each time point was measured in triplicate and the error bars represent the SD of a single
representative experiment of three performed. The inset shows Western blots of MT1-MMP expression in either control or MT-MMP
transfectants as indicated. Asterisks (*) mark the position of active MT1-MMP species whereas the arrowheads mark the position of a
membrane-anchored, catalytically inactive fragment of MT1-MMP (Mr z43 kD; Lehti et al., 1998). MT1-MMP stable transfectants did
not express detectable levels of MT2-MMP or MT3-MMP, as assessed by Western or Northern blot analysis, respectively. B, Epithelial
morphology, E-cadherin staining, and SF/HGF-induced scattering responses of control or MT1-MMP–transfected cells cultured as de-
scribed in Materials and Methods in either the absence or presence of SF/HGF. C, In the presence of SF/HGF, control vector-trans-
fected MDCK cells cultured atop type I collagen gels for 3 d display widespread, but shallow foci of invasion (arrows) as viewed en face
(top; bar, 100 mm), in cross-section (middle; bar, 100 mm), or by TEM (bottom; bar, 5 mm). In contrast, MDCK cells overexpressing
MT1-MMP generated numerous large pits in the collagen matrix (arrows) extending well below the surface monolayer as viewed en
face (top), in cross-section by light microscopy (middle) or by TEM (bottom). D, After 12 d, MT1-MMP overexpressing cells cultured in
the absence of SF/HGF formed pits in the underlying collagen gel whereas SF/HGF-stimulated cells generated interconnecting cyst-like
structures extending to the surface of the underlying polycarbonate membrane (compare to Fig. 1, A–D). Invasion by MT1-MMP trans-
fectants was inhibited completely by TIMP-2, but not TIMP-1. Bar, 100 mm. 
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whether either of these MMPs, though inactive in the
morphogenic screen when overexpressed alone, would
further modify the MT1-MMP–mediated invasion program.
However, when MT1-MMP transfectants were cultured
together at a 1:1 ratio with MDCK cells overexpressing ei-
ther MMP-2 or MMP-13, neither invasion nor tubulogene-
sis was further enhanced (Fig. 4, E and F). Likewise, when
MT1-MMP overexpressing cells (which express undetect-
able levels of endogenous MMP-2; Hiraoka et al., 1998)
were cultured in FCS depleted of MMP-2, morphogenic
responses were unaltered (data not shown).
 
MT-MMPs as Morphogenic Regulators
 
MT1-MMP is structurally related to at least two other
membrane-anchored MMPs, MT2-MMP and MT3-MMP
(Nagase and Woessner, 1999). To determine whether in-
vasion and/or branching morphogenesis could be similarly
modulated by these proteinases, we isolated and examined
stable MDCK clones that overexpressed either MT2-
MMP or MT3-MMP alone (Fig. 5 A). As shown in Fig. 5,
MT2-MMP and MT3-MMP transfectants displayed growth
patterns (data not shown) and morphologic characteristics
 
similar to control-transfected clones (Fig. 5 B). In addi-
tion, scattering responses across a plastic substratum (Fig.
5 B), as well as migratory rates across the surface of col-
lagen gels, were unaffected (563 
 
6
 
 40 
 
m
 
m/24 h, 533 
 
6
 
 38
 
m
 
m/24 h, and 575 
 
6
 
 37 
 
m
 
m/24 h, respectively, and for con-
trol, MT2-MMP, and MT3-MMP transfectants;
 
 n 
 
5 
 
3).
Unexpectedly, however, MT2-MMP transfectants stimu-
lated with SF/HGF lost almost all invasive and morpho-
genic activity in the three-dimensional collagen gel system
(Fig. 5 C). Instead, MT2-MMP–overexpressing cells formed
a disorganized multilayered structure atop the collagen
matrix. While not frankly invasive, TEM analysis demon-
strated that the SF/HGF-stimulated cells extended shal-
low, invasive processes into the collagen gel via a BB-94–
or TIMP-2–sensitive mechanism (Fig. 5 C). Membrane
anchoring of MT2-MMP was required for this effect as
MDCK transfectants overexpressing soluble MT2-MMP
displayed invasive and tubulogenic properties indistin-
guishable from control transfectants (data not shown). As
epithelial cells that overexpress active MMPs have been
reported to undergo an epithelial-to-mesenchymal cell trans-
formation (Lochter et al., 1997b), the absence of a mor-
phogenic response raised the possibility that MT2-MMP
Figure 4. Regulation of
MT1-MMP–dependent inva-
sion and tubulogenesis.
MDCK cell clones trans-
fected with a control vector
(A), MT1-MMP (B), MT1-
MMP lacking the cytosolic
domain (MT1-MMPct; C) or
soluble MT1-MMP (DMT1-
MMP; D) were cultured atop
type I collagen gels for 12 d
in complete medium with SF/
HGF. Invasive activity of
MT1-MMP overexpressing
cells was not altered when
cocultured in a 1:1 ratio with
MDCK clones overexpress-
ing MMP-2 (E) or MMP-13
(F). Bar, 100 mm. 
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transfectants had lost their epithelial cell-like characteris-
tics. However, MT2-MMP overexpressing cells expressed
a normal tubulogenic program when triggered with SF/
HGF atop thick matrices of Matrigel (Fig. 5 E).
In contrast to the characteristics displayed by either
MT1-MMP or MT2-MMP transfectants, MDCK clones over-
expressing MT3-MMP mounted a nearly normal invasive
and tubulogenic program in response to SF/HGF (Fig. 5
D). Cells overexpressing MT3-MMP invaded the collagen
substratum at rates comparable to control cells after stim-
ulation with SF/HGF and formed similar numbers of inva-
sive foci (data not shown). The depth of invasion after the
12-d culture period was, however, significantly more shal-
low in the MT3-MMP transfectants (192 
 
6
 
 29 
 
m
 
m in con-
trol transfectants versus 48 
 
6
 
 21 
 
m
 
m in MT3-MMP trans-
fectants; mean depth of invasion 
 
6
 
 1 SD in ten randomly
selected sections in a single representative experiment of
four performed) and the cells formed cyst-like structures,
rather than the tubular network normally formed by in-
vading control MDCK cells (Fig. 5 D). Similar to the find-
ings obtained with the MT1-MMP and the MT2-MMP
transfectants, the alteration in morphogenic properties
was limited to the type I collagen substratum as MT3-
MMP overexpressing MDCK cells displayed a normal tubu-
logenic response on Matrigel (Fig. 5 E).
 
MT-MMP–dependent Regulation of MDCK Invasion 
through Interstitial Stroma
 
Whereas increasing the expression of MT-MMPs in MDCK
cells altered invasion and branching morphogenesis in
type I collagen gels, this reconstituted matrix displays
physical properties distinct from those of cross-linked col-
lagen in vivo (Birkedal-Hansen, 1987; Rosenthal et al.,
1998). To determine the ability of MT-MMPs to remodel a
more physiologic matrix, control or MT-MMP transfec-
tants were cultured atop an acellular sheet of peritoneum-
derived interstitial tissue (Fig. 6). This tissue consists of a
network of type I collagen and elastin fibers sandwiched
between two discontinuous basement membranes (Fig. 6
A, inset; Parsons et al., 1983). Significantly, SF/HGF-stim-
ulated control MDCK cells were unable to cross this more
complex barrier (Fig. 6, A and D). Cells overexpressing
MT1-MMP, however, vigorously invaded the peritoneal
tissue after SF/HGF stimulation, forming large pits similar
to those seen on type I collagen and leaving only small
stretches of peritoneum intact (Fig. 6, B and D). As ex-
pected, this degradative process was inhibited completely
by TIMP-2 (data not shown) or BB-94 (Fig. 6, C and D).
An even more dramatic effect was seen with MT2-MMP
transfectants, as these cells completely degraded large
stretches of the tissue within three to four days of SF/HGF
stimulation, eventually eliminating nearly all visible tissue
via a BB-94–sensitive process (Fig. 6 E).
In marked contrast to MT1- and MT2-MMP–overex-
pressing cells, neither the MT3-MMP nor MMP-1, -2, -3, -7,
-9, -11, or -13 stable transfectants displayed invasive be-
havior on the peritoneum, and were essentially indistin-
guishable from wild-type– or control-transfected MDCK
cells (data not shown). As the dissolution of this interstitial
matrix occurred in the presence of high concentrations
of serum that contains a full complement of endogenous
proteinase inhibitors, these data demonstrate that MT1-
MMP, as well as MT2-MMP, confer MDCK cells with the
ability to digest collagen-rich tissues in an in vivo-like set-
ting.
MT1-MMP and MT2-MMP Function as
Membrane-anchored Invasive Factors
Whereas MT1-MMP and MT2-MMP modified the mor-
phogenic program displayed by SF/HGF-stimulated MDCK
cells, the ability of these enzymes to regulate collagen-
invasive activity directly cannot be ascertained by this ex-
perimental approach, as the host cell coexpresses a com-
plement of endogenously derived proteinases (Montesano
et al., 1991a,b, 1999). Consequently, COS-1 cells, which do
not express MT-MMPs (Sato et al., 1994), were transiently
transfected with MT1-, MT2-, or MT3-MMP and colla-
gen-invasive activity monitored. As shown in Fig. 7 A,
cells transfected with FLAG epitope-tagged constructs ex-
pressed each of the respective proteinases. Furthermore,
though the mature forms of MT2-MMP or MT3-MMP
have not yet been identified in the literature, the enzy-
matic activity of the proteinases was monitored indirectly
as the ability of the transfected cells to process exoge-
nously supplied progelatinase A to its mature form. Using
this assay, each of the MT-MMP transfectants displayed
comparable activity (Fig. 7 B). Significantly, when the MT-
MMP–transfected COS-1 cells were cultured atop the type
I collagen substratum, both MT1- and MT2-MMP–overex-
pressing cells acquired an invasive activity (Fig. 7, D and
E) that was inhibitable by both BB-94 and TIMP-2 (Fig. 7,
G and H). Invasion was completely dependent on mem-
Figure 5. Characterization of MT2-MMP and MT3-MMP overexpressing MDCK cells. A, Western blot analysis of MT2-MMP protein
(arrow) in Triton X-114 cell extracts of transfected cells. The expression of the MT3-MMP transcript in transfected cells was shown by
Northern blotting. A 36B4 control was run to confirm RNA integrity and equal loading. MT2-MMP stable transfectants did not express
detectable levels of MT1-MMP or MT3-MMP (Western and Northern blot analysis, respectively), whereas MT3-MMP stable transfec-
tants did not express detectable levels of MT1-MMP or MT2-MMP, as assessed by Western blot. B, Cell morphology and scattering re-
sponse to SF/HGF was unaffected by either MT2-MMP or MT3-MMP overexpression (compare to Fig. 3 B). C, Unstimulated MT2-
MMP–overexpressing cells formed a confluent monolayer on collagen as assessed in cross-sections (top left-hand corner) or by TEM
(bottom left-hand corner). Bar, 1 mm. When stimulated with SF/HGF for 12 d, MT2-MMP transfectants formed a pseudostratified-like
epithelial layer with basilar extensions intruding into the underlying collagen (arrows in light section and TEM in the middle panel of
the bottom row). The extension of these processes into the collagen was blocked by BB-94. D, Unstimulated MT3-MMP transfectants
formed a phenotypically normal confluent monolayer on type I collagen as depicted in a 12-d-old culture. When stimulated with SF/
HGF, MT3-MMP overexpressors invaded shallowly and formed cyst-like structures (shown en face, and in cross-section) distinctly dif-
ferent from control cell invasion (see Fig. 1, B and D). The invasive activity of MT3-MMP transfectants was blocked completely by BB-
94. Bar, 100 mm. E, Invasion and tubulogenesis by control vector-, MT1-MMP–, MT2-MMP–, or MT3-MMP–transfected cells cultured
atop Matrigel with SF/HGF for 12 d in complete media. Bar, 100 mm.The Journal of Cell Biology, Volume 149, 2000 1318
brane anchoring of the proteinases to the cell surface, as
COS-1 cells transiently transfected with either soluble
transmembrane-deleted MT1-MMP or MT2-MMP failed
to express an invasive phenotype (1.0 6 0.8 invasive foci/
field and 2.0 6 1.0, n 5 3; invasive foci/field for DMT1-
MMP and DMT2-MMP, respectively). MT3-MMP–trans-
fected cells extended only a few short processes into the
underlying collagen (Fig. 7 F) in a fashion similar to that
observed in control-transfected cells (Fig. 7 C). Thus, both
MT1-MMP and MT2-MMP, but not MT3-MMP, confer
invasion-null cells with the ability to penetrate type I col-
lagen matrices.
Discussion
To traverse type I collagen-rich tissues, normal, as well
Figure 6. Invasion of perito-
neal tissue by MDCK trans-
fectants in vivo. A, Vector
control-transfected MDCK
cells cultured on the perito-
neal matrix (arrow) did not
express invasive activity af-
ter stimulation with SF/HGF
for 12 d in complete media.
Bar, 100 mm. The inset shows
the peritoneal matrix by
TEM after the mesothelial
cell layers were removed.
The tissue contains numerous
collagen and elastin fibrils
sandwiched between two dis-
continuous basement mem-
branes. Bar, 1 mm. B, MT1-
MMP–overexpressing cells
degraded large blocks of tis-
sue and invaded into the un-
derlying collagen after stimu-
lation with SF/HGF for 12 d.
A small segment of remain-
ing peritoneal tissue is indi-
cated by the arrow. C, In the
presence of BB-94, MT1-
MMP transfectants failed to
invade the peritoneum after
12 d in culture (arrow). D,
TEM analysis of peritoneal
tissue invasion by control or
MT1-MMP transfectants cul-
tured for 12 d with SF/HGF
in the absence or presence of
BB-94 as indicated. Only a
portion of the peritoneum
can be identified after culture
with MT1-MMP–overexpress-
ing cells (arrow). Bar, 1 mm.
E, MT2-MMP–overexpress-
ing cells completely degraded
entire tracts of the perito-
neum after stimulation with
SF/HGF for 12 d as shown in
an en face view of a live cul-
ture. The addition of BB-94
to these cultures blocked tis-
sue dissolution and main-
tained an intact peritoneal
matrix. Bar, 100 mm.Hotary et al. Matrix Metalloprotease-dependent Invasion 1319
Figure 7. Collagen-invasive activity of MT-MMPs in transiently transfected COS-1 cells. A, Western blot analysis of COS-1 cells tran-
siently transfected with FLAG epitope-tagged MT1-, MT2-, and MT3-MMP. Triton X-114 extracts were immunoblotted with anti-
FLAG M2 mAb. B, MT-MMP activity in transiently transfected COS-1 cells was assessed by monitoring the activation of proMMP-2.
The pro, intermediate, and active forms of MMP-2 are indicated by the arrow, clear arrowhead, and black arrowhead, respectively. C,
Transverse light sections of control vector-transfected COS-1 cultured atop type I collagen gels for 5 d in the presence of SF/HGF were
unable to express invasive activity, save for the extension of short processes (arrow) into the underlying substratum. COS-1 cells over-
expressing MT1-MMP (D) or MT2-MMP (E) displayed invasive activity whereas MT3-MMP transfectants (F) were indistinguishable
from control-transfected COS-1 cells. The number of invasive foci (G) and invasion depth (H) were assessed in transverse light sections
of COS-1 cultures after a 5-d incubation period with SF/HGF in the absence or presence of BB-94 (shaded and open bars, respectively).
Results are expressed as the mean 6 1 SD in ten randomly selected cross-sections in a single representative experiment of three per-
formed. Bar, 50 mm.The Journal of Cell Biology, Volume 149, 2000 1320
as neoplastic, cells coordinately express motile and col-
lagenolytic phenotypes (Werb, 1997; Murphy and Gav-
rilovic, 1999). Though multiple MMP family members can
proteolyze fibrillar collagens (Pulcher et al., 1997; Benbow
et al., 1999; Nagase and Woessner, 1999), the ability of
these enzymes to promote or modify invasive activity
through tissue barriers comprised of type I collagen has
not been defined. MT1-MMP is the prototypical member
of the subclass of membrane-anchored MMPs that display
unique characteristics relative to the larger family of se-
creted MMPs (Nagase and Woessner, 1999). Like MT2-
and MT3-MMPs (as well as the more recently described
MT5- and MT6-MMPs; Llano et al., 1999; Pei, 1999a,b;
Velasco et al., 2000), MT1-MMP has a short stretch of hy-
drophobic amino acids near its COOH terminus that is
embedded in the plasma membrane (Nagase and Woess-
ner, 1999). MT1-MMP also contains a basic motif (i.e.,
108RRKR) at the COOH-terminal end of its prodomain
that can act as a recognition site for proteolysis by one or
more members of the proprotein convertase family (Sato
et al., 1994; Pei and Weiss, 1996). Thus, whereas all se-
creted MMPs (with the exception of stromelysin-3, which
contains a similar recognition motif; Pei and Weiss, 1995;
Santavicca et al., 1996) are normally released as proen-
zymes, the MT1-MMP prodomain can be removed, and
the active enzyme generated before, or coincident with, its
delivery to the cell surface (Pei and Weiss, 1996; Sato et
al., 1996; Yana and Weiss, 2000). Activation schemes for
MT2-MMP or MT3-MMP have not been delineated to
date, but given the presence of similar basic recognition
motifs in homologous regions of their prodomains (Na-
gase and Woessner, 1999), these enzymes are likely pro-
cessed to their mature forms via similar mechanisms.
MMP family members can potentially cleave integrins
and cadherins, as well as other surface-associated mole-
cules that can initiate a process leading to stable epithelial-
to-mesenchymal conversion (Lochter et al., 1997b; Werb,
1997; Sternlicht et al., 1999). Consequently, we predicted
that cells overexpressing MT-MMPs would display aber-
rant phenotypic characteristics similar to those described
previously (Lochter et al., 1997b). However, neither MT1-,
2-, nor 3-MMP affected MDCK proliferation, cell–cell
interactions, or scattering responses to SF/HGF. Further-
more, all of the MT-MMP transfectants retained the ability
to generate patent tubular networks in Matrigel. MT1-MMP
overexpressing clones did, however, display a markedly
enhanced ability to invade type I collagen matrices result-
ing in the formation of cyst-like structures that eventually
dissolved the underlying matrix. Interestingly, the trans-
formation of a branching tubulogenesis-like program into
one more reminiscent of cyst development has been ob-
served in collagenase-treated embryonic submandibular
glands induced to undergo branching in vitro (Fukuda et
al., 1988). MT1-MMP similarly disrupted the tubulogenic
activity of SF/HGF-treated MDCK cells, presumably by
degrading the collagen matrix at a rate permissive for in-
vasion, but not branching.
Recent studies have suggested that MT-MMP functional
activity requires its regulated trafficking to the plasma
membrane via a mechanism that is partially dependent on
the COOH-terminal valine found at the end of the cyto-
solic tails of MT1-, MT2-, and MT3-MMP (Urena et al.,
1999). Furthermore, on the cell surface, MT1-MMP has
been reported to concentrate into discrete zones near the
invading front via additional targeting sequences embed-
ded in the metalloproteinase’s transmembrane domain
and/or cytosolic tail (Nakahara et al., 1997). In this man-
ner, MT1-MMP localized to the cell–substratum interface
could mediate collagenolytic effects directly or indirectly
by processing other collagenolytic enzymes to their active
forms (i.e., progelatinase A or procollagenase-3; Sato et
al., 1994; Knauper et al., 1996). However, in our system,
the cytosolic tail-deleted mutant was not only processed to
its mature form in normal fashion, but it also induced an
invasive program indistinguishable from that of the wild-
type enzyme. Similarly, we have also determined that a
chimeric construct of MT1-MMP, wherein the wild-type
transmembrane domain and tail has been replaced, also
retains full invasive activity (our unpublished observa-
tion). Whereas neither the cytosolic tail nor the transmem-
brane domain of MT1-MMP appear to encode critical
signals, membrane anchoring to the cell surface proved es-
sential to the invasive process. When MDCK or COS-1
cells were transfected with a soluble form of the enzyme
that expresses type I collagenolytic activity (D’Ortho et
al., 1997; Ohuchi et al., 1997), the invasive phenotype of
these MDCK clones reverted to that observed in the con-
trol transfectants. Thus, MT1-MMP only confers invasive
activity when confined to the pericellular compartment
where it can be concentrated at the cell–substratum inter-
face into sequestered zones that would presumably opti-
mize enzyme–substrate interactions, as well as restrict the
access of circulating proteinase inhibitors. Membrane
anchoring of MT1-MMP can also accelerate the enzyme’s
ability to catalyze proMMP-2 activation (Nagase and
Woessner, 1999), but we were unable to implicate MMP-2
in the invasion process. Whereas previous studies have
suggested that MMP-2 can act as a type I collagenase
(Aimes and Quigley, 1995), these conclusions have re-
cently been questioned (Seltzer and Eisen, 1999).
Given the ability of MT1-MMP to modify the invasive
activities of recipient cells, we predicted that similar ef-
fects might be obtained with MT2-MMP and MT3-MMP.
However, despite the facts that the overall domain struc-
tures of MT2- and MT3-MMP are virtually identical to
that of MT1-MMP, and the enzymes display similar abili-
ties to activate progelatinase A (Nagase and Woessner,
1999), each of the proteinases affected invasion in a man-
ner distinct from that observed with MT1-MMP. In the
case of MT2-MMP, the morphogenic program of SF/HGF-
stimulated MDCK cells was completely ablated, even
though the cells displayed an epithelial phenotype and
scattered in response to SF/HGF. Interestingly, whereas
MT2-MMP transfectants were unable to express a tubulo-
genic phenotype in type I collagen gels, foci of degradative
activity were identified along the basilar face of SF/HGF-
stimulated cells. As MT2-MMP transfectants retained nor-
mal invasive activity when stimulated atop Matrigel, we
posited that MT2-MMP disrupted type I collagen invasion
by degrading the underlying substratum in a discoordi-
nated fashion that prevented the cells from establishing
the adhesive interactions necessary for migration. Indeed,
when MT2-MMP transfectants were cultured atop the
peritoneum in an effort to present the cells with a moreHotary et al. Matrix Metalloprotease-dependent Invasion 1321
protease-resistant matrix, the cells not only invaded, but
actually dissolved the peritoneum despite the presence of
serum antiproteinases. We cannot rule out the possibility
that MT2-MMP penetrated the peritoneum by degrading
extracellular matrix components other than type I col-
lagen, or that MT2-MMP interacted with an as yet uniden-
tified MDCK-derived proteinase. However, COS-1 cells
transfected with full-length, but not soluble, MT2-MMP
expressed a collagen-invasive activity similar to that ob-
served with MT1-MMP–transfected cells. Most probably,
COS-1 cells regulated MT2-MMP expression and motility
in a more balanced fashion than the MDCK transfectants,
thus allowing invasion to proceed. Recently, D’Ortho et al.
(1997) reported that soluble MT2-MMP cannot degrade
type I collagen, but the membrane-anchored form of the en-
zyme appears to express activities distinct from those dis-
played by the truncated proteinase. Nonetheless, we do note
that MT2-MMP was not as efficient as MT1-MMP in driving
collagen invasion. Whether these differences reflect differ-
ences in the enzymes’ respective substrate repertoires or the
efficiency with which the metalloproteinase zymogens are
processed to their active forms remains to be determined.
The ability of MT1-MMP and MT2-MMP to regulate in-
vasive activity is consistent with recent studies demon-
strating that these two proteinases are widely expressed in
normal tissues, as well as a variety of carcinomatous states
(e.g., Ueno et al., 1997; Polette and Birembaut, 1998; Na-
kada et al., 1999). However, MT3-MMP expression ap-
pears to be much more restricted in both normal and neo-
plastic tissues (e.g., Ueno et al., 1997; Nakada et al., 1999).
In contrast to MT1-MMP and MT2-MMP, MT3-MMP
only subtly modified the SF/HGF-induced response by fa-
voring a more cyst-like morphogenic program. Based on
recent studies of recombinant soluble MT3-MMP (Shi-
mada et al., 1999), this effect could be due to the ability of
the proteinase to partially solubilize intact type I collagen
by cleaving within the telopeptide regions that harbor in-
terchain cross-links, degrading gelatin (i.e., denatured type
I collagen) after proteolysis of type I collagen, or hydrolyz-
ing MDCK-derived extracellular matrix molecules and
generating bioactive fragments capable of altering cell
function (Werb, 1997). The inability of MT3-MMP to pro-
mote collagen-invasive activity should not be miscon-
strued to suggest that the proteinase cannot affect invasive
activity through other biologically relevant matrices. Solu-
ble MT3-MMP has been reported to degrade fibrillar type
III collagen (Shimada et al., 1999) and we have also deter-
mined that MT3-MMP overexpressing MDCK cells dis-
play marked fibrin-invasive activity (our unpublished ob-
servation). Thus, we favor a scenario in which distinct
MT-MMPs promote invasive and/or morphogenic re-
sponses in a manner dictated by the enzymes’ proteolytic
profile and the characteristics of the connective tissue bar-
rier confronting the cell (e.g., Belien et al., 1999; Kosh-
ikawa et al., 2000).
Given the ability of MT-MMPs to affect invasive activ-
ity, it was surprising that none of the secreted MMPs that
we tested altered the MDCK or COS cell phenotypes in a
discernable fashion. However, three issues bear consider-
ation. First, few in vitro or in vivo studies have directly ex-
amined the role of specific MMPs in type I collagen inva-
sion (Benbow et al., 1999). In vitro, MMP-9 and MMP-3
are the only metalloproteinases that have been indirectly
linked to cell invasion programs through type I collagen
gels (Lochter et al., 1997a; Mason et al., 1999). MMP-1 has
also been reported to play a required role in keratinocyte
migration across type I collagen-coated surfaces in vitro,
but invasion was not examined (Pulcher et al., 1997). In
our studies, no effects were observed on either cell migra-
tion, invasion, or morphogenesis when any of these MMPs
were overexpressed. In this regard, it is worth noting that
in vivo studies with MMP-22/2, MMP-32/2, MMP-72/2,
and MMP-112/2 mice have demonstrated that these ani-
mals develop normally and display only subtle defects in
their ability to remodel the extracellular matrix (Duns-
more et al., 1998; Itoh et al., 1998; Liu et al., 1998; Masson
et al., 1998; Mudgett et al., 1998; Wang et al., 1999). MMP-
92/2 mice exhibit abnormal patterns of skeletal growth
plate vascularization and ossification, but interestingly, de-
fects are temporary and primarily restricted to bone where
MMP-9 acts as an angiogenic activator (Vu et al., 1998).
MMP-9 has also been reported to participate in renal mor-
phogenesis in vitro, but similar effects in knockout mice
have not yet been described (Lelongt et al., 1997).
The somewhat limited effects of deleting soluble mem-
bers of the MMP family stand in marked contrast to the
more global and severe defects recently observed in MT1-
MMP2/2 mice (Holmbeck et al., 1999). In these animals,
dwarfism, osteopenia, arthritis, and premature mortality
have been primarily attributed to defects in type I collagen
turnover. Interestingly, renal epithelial cells undergoing
branching morphogenesis in vivo have been shown to
transiently express MT1-MMP (Ota et al., 1998; Tanney et
al., 1998). Furthermore, as MDCK cells can express low
levels of MT1-MMP in vitro (Kadono et al., 1998; our un-
published observation), MT-MMPs may well participate in
morphogenic programs in vivo. Specific defects in col-
lagen-invasive or branching activity have not yet been ex-
amined in MT1-MMP2/2 mice, but the multiple and severe
defects that occur in these animals highlight the relative
importance of membrane-anchored MMPs.
Second, despite the relative paucity of studies attempt-
ing to determine the means by which invading cells re-
model type I collagen in vitro or in knockout animals,
alterations in extracellular matrix structure/function have
been observed in transgenic animals engineered to overex-
press MMP-1, -3, or -7 (e.g., Sympson et al., 1994; Witty et
al., 1995; D’Armiento et al., 1995; Rudolph-Owen et al.,
1998; Sternlicht et al., 1999). However, these effects are
complicated by the fact that MMPs induce epithelial-
to-mesenchymal cell conversions in vivo with attendant
changes in the expression profile of affected cell popula-
tions (Sternlicht et al., 1999). These types of analyses
clearly underline the importance of MMPs in regulating
tissue architecture and function, but the role of individual
proteinases remains difficult to establish.
Finally, the above issues notwithstanding, increasing ev-
idence suggests that the matrix remodeling events that oc-
cur coincident with invasive or morphogenic processes are
most efficiently mediated by cell surface-associated pro-
teinases. In this manner, a balance is struck between pro-
teolysis and motility such that sufficient matrix is cleared
to allow forward movement while leaving a substrate un-
derfoot for propulsive movement (Werb, 1997; Hiraoka etThe Journal of Cell Biology, Volume 149, 2000 1322
al., 1998; Murphy and Gavrilovic, 1999). MT-MMPs may
be specifically adapted for this purpose as the proteinases
are activated and then tethered to the cell surface. Indeed,
when either MT1- or MT2-MMP were truncated to gener-
ate secreted proteinases, all proinvasive effects were lost,
despite the fact that the enzymes are efficiently processed
to their active forms. Similarly, though MDCK clones
overexpressing MMP-2, -3, or -11 were each able to acti-
vate a portion of the secreted metalloproteinase, no effect
on invasion or tubulogenesis was observed. Thus, the in-
ability of secreted MMPs to participate in invasive events
most likely reflects their inefficient localization to the sur-
face of MDCK or COS cells. Indeed, under appropriate
conditions, even secreted proteinases may display impor-
tant functional activities after membrane binding. For ex-
ample, active MMP-2 can associate with the integrin avb3,
whereas MMP-9 can bind to cell surfaces via interactions
with the a2(IV) chain of collagen or CD44 (Brooks et al.,
1996; Olson et al., 1998; Yu and Stamenkovic, 2000). In the
latter case, a membrane-anchored, but not soluble, mutant
form of MMP-9 was shown to regulate tumor invasion
and angiogenesis (Yu and Stamenkovic, 2000). Taken to-
gether, these data suggest that either membrane-anchored
or membrane-associated proteinases are ideally posi-
tioned for regulating movement through three-dimen-
sional structures. Given the multiple normal and neoplas-
tic cell types known to express MT-MMPs, we posit that
this class of enzymes will prove to play key roles in allow-
ing invading cells to negotiate and remodel interstitial ma-
trix barriers.
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